Variant | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AF EXOME | AF GENOME | Disease | Disease Class | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
6 | 160157828 | intron variant | T/C | snv | 0.14 |
|
0.800 | 1.000 | 4 | 2010 | 2019 | ||||||||||
|
6 | 160157828 | intron variant | T/C | snv | 0.14 |
|
0.800 | 1.000 | 4 | 2010 | 2019 | ||||||||||
|
0.925 | 0.080 | 6 | 160160511 | downstream gene variant | -/G | delins | 0.31 |
|
Neoplasms; Male Urogenital Diseases | 0.710 | 1.000 | 1 | 2015 | 2015 | |||||||
|
1.000 | 0.080 | 6 | 160122116 | missense variant | C/T | snv | 5.2E-02 | 4.9E-02 |
|
0.700 | 1.000 | 2 | 2015 | 2018 | |||||||
|
6 | 160157828 | intron variant | T/C | snv | 0.14 |
|
0.700 | 1.000 | 2 | 2010 | 2013 | ||||||||||
|
1.000 | 0.080 | 6 | 160154953 | intron variant | C/T | snv | 0.37 | 0.42 |
|
0.700 | 1.000 | 2 | 2018 | 2019 | |||||||
|
0.882 | 0.160 | 6 | 160160342 | downstream gene variant | A/G | snv | 0.69 |
|
Neoplasms; Male Urogenital Diseases | 0.700 | 1.000 | 2 | 2009 | 2011 | |||||||
|
0.882 | 0.160 | 6 | 160160342 | downstream gene variant | A/G | snv | 0.69 |
|
Neoplasms; Male Urogenital Diseases | 0.700 | 1.000 | 2 | 2009 | 2011 | |||||||
|
1.000 | 0.080 | 6 | 160130454 | intron variant | C/A;T | snv |
|
Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases | 0.700 | 1.000 | 1 | 2018 | 2018 | ||||||||
|
1.000 | 0.080 | 6 | 160130454 | intron variant | C/A;T | snv |
|
Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases | 0.700 | 1.000 | 1 | 2018 | 2018 | ||||||||
|
6 | 160154334 | intron variant | G/A | snv | 0.12 |
|
0.700 | 1.000 | 1 | 2018 | 2018 | ||||||||||
|
6 | 160154334 | intron variant | G/A | snv | 0.12 |
|
0.700 | 1.000 | 1 | 2018 | 2018 | ||||||||||
|
1.000 | 0.080 | 6 | 160122116 | missense variant | C/T | snv | 5.2E-02 | 4.9E-02 |
|
0.700 | 1.000 | 1 | 2018 | 2018 | |||||||
|
1.000 | 0.080 | 6 | 160122116 | missense variant | C/T | snv | 5.2E-02 | 4.9E-02 |
|
0.700 | 1.000 | 1 | 2018 | 2018 | |||||||
|
1.000 | 0.080 | 6 | 160154953 | intron variant | C/T | snv | 0.37 | 0.42 |
|
0.700 | 1.000 | 1 | 2018 | 2018 | |||||||
|
1.000 | 0.040 | 6 | 160134990 | intron variant | G/T | snv | 0.19 |
|
Neoplasms | 0.700 | 1.000 | 1 | 2017 | 2017 | |||||||
|
1.000 | 0.040 | 6 | 160134722 | intron variant | G/A | snv | 0.64 |
|
Neoplasms | 0.700 | 1.000 | 1 | 2017 | 2017 | |||||||
|
6 | 160148036 | intron variant | C/T | snv | 0.13 |
|
0.700 | 1.000 | 1 | 2017 | 2017 | ||||||||||
|
0.882 | 0.160 | 6 | 160160342 | downstream gene variant | A/G | snv | 0.69 |
|
Neoplasms; Stomatognathic Diseases; Otorhinolaryngologic Diseases | 0.700 | 1.000 | 1 | 2010 | 2010 | |||||||
|
6 | 160143444 | intron variant | C/G | snv | 0.14 |
|
0.700 | 1.000 | 1 | 2011 | 2011 | ||||||||||
|
6 | 160143444 | intron variant | C/G | snv | 0.14 |
|
0.700 | 1.000 | 1 | 2011 | 2011 | ||||||||||
|
0.807 | 0.360 | 6 | 160130172 | missense variant | G/A;C;T | snv | 4.0E-06; 0.83; 4.0E-06 |
|
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Nutritional and Metabolic Diseases; Musculoskeletal Diseases | 0.700 | 1.000 | 1 | 2012 | 2012 | |||||||
|
0.807 | 0.360 | 6 | 160130172 | missense variant | G/A;C;T | snv | 4.0E-06; 0.83; 4.0E-06 |
|
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Nutritional and Metabolic Diseases; Musculoskeletal Diseases | 0.700 | 1.000 | 1 | 2012 | 2012 | |||||||
|
1.000 | 0.040 | 6 | 160157239 | intron variant | G/T | snv | 0.42 |
|
Cardiovascular Diseases | 0.700 | 1.000 | 1 | 2012 | 2012 | |||||||
|
0.882 | 0.280 | 6 | 160151834 | intron variant | C/A | snv | 0.70 |
|
Pathological Conditions, Signs and Symptoms; Digestive System Diseases | 0.020 | 1.000 | 2 | 2014 | 2015 |